Table 2 Effects of various risk factors on hypoglycemia occurrence in 4,501 infants born at 32–36 gestational weeks.
Risk factorsa | Univariate analysis | Multivariable analysisb | ||||
---|---|---|---|---|---|---|
Crude odds ratio (95% CI) | P-value | Adjusted odds ratio (95% CI) | P-value | |||
Combination of MgSO4 and ritodrine | ||||||
MgSO4 alone vs. no usage | 0.89 | (0.63–1.24) | 0.489 | 0.81 | (0.56–1.16) | 0.244 |
Ritodrine alone vs. no usage | 2.49 | (2.15–2.88) | <0.001 | 2.58 | (2.21–3.01) | <0.001 |
Both MgSO4 and ritodrine vs. no usage | 2.64 | (2.20–3.16) | <0.001 | 2.59 | (2.13–3.15) | <0.001 |
Obstetrical complications | ||||||
pPROM | 0.61 | (0.52–0.71) | <0.001 | 0.72 | (0.61–0.85) | <0.001 |
GH/PE/eclampsia/HELLP/AFLP | 0.83 | (0.70–0.996) | 0.045 | 0.91 | (0.74–1.12) | 0.355 |
Placental abruption | 0.83 | (0.56–1.22) | 0.332 | 0.91 | (0.60–1.38) | 0.670 |
Placenta previa/Low lying placenta | 1.39 | (1.09–1.78) | 0.008 | 0.96 | (0.74–1.26) | 0.782 |
DM | 1.15 | (0.62–2.13) | 0.649 | 1.62 | (0.85–3.08) | 0.145 |
GDM | 1.01 | (0.77–1.34) | 0.937 | 1.14 | (0.85–1.54) | 0.372 |
Cesarean section | 2.14 | (1.86–2.46) | <0.001 | 1.96 | (1.67–2.31) | <0.001 |
Delivery at <35 wk | 1.01 | (0.89–1.15) | 0.898 | 0.95 | (0.82–1.09) | 0.646 |
Twins/triplets | 1.91 | (1.67–2.18) | <0.001 | 1.23 | (1.06–1.44) | 0.009 |
Sex: male | 0.89 | (0.79–1.01) | 0.068 | 0.91 | (0.80–1.04) | 0.166 |
SGA infants | 1.23 | (1.02–1.48) | 0.033 | 1.35 | (1.10–1.65) | 0.004 |
Large-for-gestational-age infants | 1.14 | (0.64–2.03) | 0.656 | 1.58 | (0.85–2.94) | 0.146 |
Apgar score at 1 min <3 | 0.96 | (0.67–1.39) | 0.846 | 0.98 | (0.66–1.45) | 0.917 |